Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Metabolic Syndrome D024821 44 associated lipids
Hyperuricemia D033461 4 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Atherosclerosis D050197 85 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Mucositis D052016 7 associated lipids
Acute Lung Injury D055371 33 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Oxholm P and Winther K Thrombocyte involvement in immune inflammatory reactions. 1986 Allergy pmid:3515999
Wallace JL and Whittle BJ Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. 1986 Prostaglandins pmid:3726156
DeFeudis FV Possible relationship between the syntheses of endothelium-derived relaxing factor (EDRF) and PAF-acether. 1986 Gen. Pharmacol. pmid:3516791
Eche N et al. Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). 1986 Thromb. Res. pmid:3726808
Camussi G Potential role of platelet-activating factor in renal pathophysiology. 1986 Kidney Int. pmid:3517457
Hoffman DR et al. The role of platelet-activating factor in human fetal lung maturation. 1986 Am. J. Obstet. Gynecol. pmid:3728606
Sybertz EJ et al. AGEPC, a vasodilator phospholipid with profound circulatory actions. 1986 Prog. Clin. Biol. Res. pmid:3538024
McGowan HM et al. Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat. 1986 Am. J. Physiol. pmid:3538908
Hsueh W et al. Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. 1986 Eur. J. Pharmacol. pmid:3754817
Hemmendinger S et al. [Methods of studying platelet function. Biological markers of the activation of human platelets in vivo and in vitro]. 1986 Ann. Biol. Clin. (Paris) pmid:3538949
Okamoto M et al. Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. 1986 Thromb. Res. pmid:3754990
Alloatti G et al. Effect of platelet-activating factor (PAF) on human cardiac muscle. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3941007
Oh-ishi S et al. Suppression of phorbol myristate acetate-induced pleurisy by CV-3988, an antagonist of platelet-activating factor. 1986 Chem. Pharm. Bull. pmid:3829203
Resink TJ et al. The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. 1986 Biochem. Biophys. Res. Commun. pmid:2943273
Gay JC et al. Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. 1986 Blood pmid:3006836
Wade PJ et al. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. 1986 Thromb. Res. pmid:3961730
Kikawa Y et al. Leukotriene B4 biosynthesis in polymorphonuclear leukocytes from blood of umbilical cord, infants, children, and adults. 1986 Pediatr. Res. pmid:3012451
Bussolino F et al. Production of platelet-activating factor by chick retina. 1986 J. Biol. Chem. pmid:3023352
Cox CP Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. 1986 Thromb. Res. pmid:2421432
Okamoto M et al. Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives. 1986 Chem. Pharm. Bull. pmid:2421923
Morley J et al. Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. 1986 Ann Allergy pmid:3083731
McIntosh TK and Faden AI Thyrotropin-releasing hormone (TRH) and circulatory shock. 1986 Circ. Shock pmid:3084122
Raphael GD and Metcalfe DD Mediators of airway inflammation. 1986 Eur J Respir Dis Suppl pmid:2429857
Oh S et al. Inflammatory effects of acetylglycerylether phosphorylcholine: vascular permeability increase and induction of pleurisy in rats. 1986 Prostaglandins Leukot Med pmid:3459197
Newhouse MT and Sears MR Platelet activating factor, ketotifen and asthma. 1986 N. Z. Med. J. pmid:3462569
Goldstein RE et al. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. 1986 Pharmacol Res Commun pmid:3774842
Plante GE et al. Hemodynamic effects of PAF-acether. 1986 Pharmacol Res Commun pmid:3774843
Lee TC et al. A new de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor. Biochemical characterization of 1-alkyl-2-lyso-sn-glycero-3-P:acetyl-CoA acetyltransferase in rat spleen. 1986 J. Biol. Chem. pmid:3007498
Rosam AC et al. Potent ulcerogenic actions of platelet-activating factor on the stomach. 1986 Jan 2-8 Nature pmid:3510396
Kako KJ Membrane phospholipids and plasmalogens in the ischemic myocardium. 1986 May-Jun Can J Cardiol pmid:2424580
von Tscharner V et al. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. 1986 Nov 27-Dec 3 Nature pmid:2431318
Benhamou M and Mencia-Huerta JM Effect of glucocorticosteroids on the expression of Fc epsilon R1 and on mediator release from mast cells. 1986 Sep-Oct Ann. Inst. Pasteur Immunol. pmid:2948525
Morley J Theophylline in asthma. 1986 Sep-Oct Bull Eur Physiopathol Respir pmid:3801711
Joly F et al. Ketotifen inhibits paf-acether biosynthesis and beta-hexosaminidase release in mouse mast cells stimulated with antigen. 1987 Eur. J. Pharmacol. pmid:2963750
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
Gautheron PD et al. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731. 1987 J. Pharm. Pharmacol. pmid:2891830
Kornecki E et al. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. 1987 Adv. Exp. Med. Biol. pmid:2893525
Gordeev KIu et al. [Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor]. 1987 Bioorg. Khim. pmid:3566815
Stahl GL and Lefer AM Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. 1987 Blood Vessels pmid:3567363
Hannun YA et al. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. 1987 J. Biol. Chem. pmid:3115982
Sipka S et al. Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. 1987 Acta Biochim. Biophys. Hung. pmid:3132002
Rylander R and Beijer L Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3541718
Dejana E et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. 1987 Blood pmid:3542082
Lucchesi BR et al. Interaction of the formed elements of blood with the coronary vasculature in vivo. 1987 Fed. Proc. pmid:3542578
Stafforini DM et al. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. 1987 J. Biol. Chem. pmid:3549727
Nunez D et al. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions]. 1987 Pathol. Biol. pmid:3550639
Maguire MH and Csonka-Khalifah L Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs. 1987 Biochim. Biophys. Acta pmid:3117116
Blache D and Ciavatti M Rat platelet arachidonate metabolism in the presence of Ca2+, Sr2+ and Ba2+: studies using intact platelets and semi-purified phospholipase A2. 1987 Biochim. Biophys. Acta pmid:2444263
Christman BW et al. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. 1987 Am. Rev. Respir. Dis. pmid:3592402
Benveniste J A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity? 1987 Am. Rev. Respir. Dis. pmid:3592414
Tokumura A et al. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain. 1987 Biochem. Biophys. Res. Commun. pmid:3593346
Kojima S et al. Cooperativity between platelet-activating factor and collagen in platelet aggregation. 1987 Biochem. Biophys. Res. Commun. pmid:3593379
Lapointe DS et al. Mobilization of hepatic calcium pools by platelet activating factor. 1987 Biochemistry pmid:3593678
Fujita K et al. Synthesis and biological activity of fluorine-modified platelet activating factors. 1987 Chem. Pharm. Bull. pmid:3594676
O'Neill C et al. Use of a bioassay for embryo-derived platelet-activating factor as a means of assessing quality and pregnancy potential of human embryos. 1987 Fertil. Steril. pmid:3595903
Sugatani J et al. Platelet-activating factor stimulation of rabbit platelets is blocked by serine protease inhibitor (chymotryptic protease inhibitor). 1987 J. Biol. Chem. pmid:3106343
Stenmark KR et al. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. 1987 Am. Rev. Respir. Dis. pmid:3631747
O'Donnell SR and Barnett CJ Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. 1987 Eur. J. Pharmacol. pmid:3040440
Okayasu T et al. Platelet-activating factor stimulates metabolism of phosphoinositides via phospholipase A2 in primary cultured rat hepatocytes. 1987 J. Lipid Res. pmid:3040878
Deguchi K et al. [Platelet activating factor]. 1987 Nippon Rinsho pmid:3041069
Neuwirth R et al. Effect of platelet activating factor antagonists on cultured rat mesangial cells. 1987 J. Pharmacol. Exp. Ther. pmid:3119816
Fennessy MR et al. Lipid mediators of anaphylaxis and increased airways reactivity. 1987 Clin. Exp. Pharmacol. Physiol. pmid:2824102
Nakamura T et al. Platelet-activating factor in late asthmatic response. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3804454
Wallace JL et al. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. 1987 Gastroenterology pmid:3305134
Barnes PJ The changing face of asthma. 1987 Q. J. Med. pmid:3310071
Schellenberg RR Airway responses to platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3310779
Makowka L et al. Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. 1987 Ann. Surg. pmid:3310931
Hanahan DJ and Kumar R Platelet activating factor; chemical and biochemical characteristics. 1987 Prog. Lipid Res. pmid:3313430
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Chabot MC et al. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. 1987 Biochim. Biophys. Acta pmid:2823907
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Zimmerman GA et al. Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. 1987 Am. Rev. Respir. Dis. pmid:3300444
Murphy RC and Clay KL Measurement of platelet-activating factor by physicochemical technique s. 1987 Am. Rev. Respir. Dis. pmid:3300445
Braquet P et al. Perspectives in platelet-activating factor research. 1987 Pharmacol. Rev. pmid:3303066
Chen DC [Phosphoinositide metabolism and platelet activation]. 1987 Sheng Li Ke Xue Jin Zhan pmid:2838899
Murphy WG et al. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. 1987 Br. J. Haematol. pmid:3499167
Sudan BJ Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis. 1987 Med. Hypotheses pmid:2886895
Piper PJ and Stewart AG Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. 1987 Br. J. Pharmacol. pmid:3034369
Ostermann G et al. Modification of the polar head group of platelet-activating factor: influence on the biological activity. 1987 Chem. Phys. Lipids pmid:3607969
Hwang SB Specific receptor sites for platelet activating factor on rat liver plasma membranes. 1987 Arch. Biochem. Biophys. pmid:2821908
Robaut C et al. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. 1987 Biochem. Pharmacol. pmid:2822048
Dale MM and Penfield A Comparison of the effects of indomethacin, RHC80267 and R59022 on superoxide production by 1,oleoyl-2,acetyl glycerol and A23187 in human neutrophils. 1987 Br. J. Pharmacol. pmid:2822195
Leff AR et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. 1987 J. Appl. Physiol. pmid:2881917
McIntyre TM et al. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. 1987 J. Biol. Chem. pmid:2824456
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Khandwala A et al. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. 1987 Biochem. Pharmacol. pmid:2435293
Hartiala KT et al. Lack of correlation between calcium mobilization and respiratory burst activation induced by chemotactic factors in rabbit polymorphonuclear leukocytes. 1987 Biochem. Biophys. Res. Commun. pmid:3034265
Alloatti G et al. Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor. 1987 J. Cardiovasc. Pharmacol. pmid:2435996
Kappa JR et al. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). 1987 J. Vasc. Surg. pmid:2437338
Serafin WE and Austen KF Mediators of immediate hypersensitivity reactions. 1987 N. Engl. J. Med. pmid:2438554
Avdonin PV et al. Evidence for the receptor-operated calcium channels in human platelet plasma membrane. 1987 Thromb. Res. pmid:2438805
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Morley J and Sanjar S PAF, ketotifen and asthma. 1987 N. Z. Med. J. pmid:3468405
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Shalit M et al. Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. 1987 Blood pmid:3118991
Sheth KJ et al. Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchanges. 1987 Clin Pediatr (Phila) pmid:3119270
Sage SO and Rink TJ The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. 1987 J. Biol. Chem. pmid:3119586
Camussi G et al. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. 1987 J. Exp. Med. pmid:3119758
Sweatt JD et al. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. 1987 Circ. Res. pmid:2822286